We have previously shown that approximately 20% of pTERT wild-type glioblastomas (GBM) activate ALT, most without detectable ATRX loss by IHC, and that these tumors tend to have a better prognosis [21, 27]. The gene discussed is GPT; the disease is glioblastoma.